| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.0M | — |
| R&D Expense | $5.3M | -39.1% |
| SG&A Expense | $5.2M | -4.4% |
| Operating Income | -$9.9M | +32.3% |
| Pre-tax Income | -$8.6M | +39.1% |
| Income Tax | $3K | +8.0% |
| Net Income | -$8.6M | +39.1% |
| EPS (Basic) | -$0.17 | +41.4% |
| EPS (Diluted) | -$0.17 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $51.0M | +175.6% |
| Short-term Investments | $40.0M | +0.0% |
| Current Assets | $51.2M | -13.2% |
| Total Assets | $66.3M | -10.6% |
| Current Liabilities | $3.3M | +2.9% |
| Total Liabilities | $3.9M | -0.5% |
| Stockholders' Equity | $62.4M | -11.2% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$7.4M | +42.4% |
| Capital Expenditures | $21K | +325.1% |
| Investing Cash Flow | $39.9M | +199.8% |
| Financing Cash Flow | $8K | +0.0% |
| Free Cash Flow | -$7.5M | +42.3% |
| +41.4% |